BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28992104)

  • 61. A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer's Disease Diagnosis Using Targeted Proteomics and Machine Learning.
    Hällqvist J; Pinto RC; Heywood WE; Cordey J; Foulkes AJM; Slattery CF; Leckey CA; Murphy EC; Zetterberg H; Schott JM; Mills K; Paterson RW
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762058
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Modeling neurological and psychiatric disorders in vitro using induced pluripotent stem cells: highlighting findings in Alzheimer's disease and schizophrenia].
    Hathy E; Kalman S; Apati A; Nemoda Z; Rethelyi JM
    Neuropsychopharmacol Hung; 2016 Dec; 18(4):188-198. PubMed ID: 28259862
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rapid and deep profiling of human induced pluripotent stem cell proteome by one-shot NanoLC-MS/MS analysis with meter-scale monolithic silica columns.
    Yamana R; Iwasaki M; Wakabayashi M; Nakagawa M; Yamanaka S; Ishihama Y
    J Proteome Res; 2013 Jan; 12(1):214-21. PubMed ID: 23210603
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuron-glia interactions: Molecular basis of alzheimer's disease and applications of neuroproteomics.
    Ibrahim AM; Pottoo FH; Dahiya ES; Khan FA; Kumar JBS
    Eur J Neurosci; 2020 Jul; 52(2):2931-2943. PubMed ID: 32463535
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Liquid chromatography-tandem mass spectrometry method for determination of panel of neurotransmitters in cerebrospinal fluid from the rat model for tauopathy.
    Kovac A; Somikova Z; Zilka N; Novak M
    Talanta; 2014 Feb; 119():284-90. PubMed ID: 24401416
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The future of stem cell therapies of Alzheimer's disease.
    Wang ZB; Wang ZT; Sun Y; Tan L; Yu JT
    Ageing Res Rev; 2022 Sep; 80():101655. PubMed ID: 35660003
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Deciphering the Proteome Dynamics during Development of Neurons Derived from Induced Pluripotent Stem Cells.
    Varderidou-Minasian S; Verheijen BM; Schätzle P; Hoogenraad CC; Pasterkamp RJ; Altelaar M
    J Proteome Res; 2020 Jun; 19(6):2391-2403. PubMed ID: 32357013
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System.
    Hu W; He Y; Xiong Y; Lu H; Chen H; Hou L; Qiu Z; Fang Y; Zhang S
    Mol Neurobiol; 2016 Apr; 53(3):1589-1600. PubMed ID: 25663198
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells.
    Kim SY; Kim MJ; Jung H; Kim WK; Kwon SO; Son MJ; Jang IS; Choi JS; Park SG; Park BC; Han YM; Lee SC; Cho YS; Bae KH
    Stem Cells Dev; 2012 May; 21(8):1272-86. PubMed ID: 21787230
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of amino acid and monoamine neurotransmitters and their metabolites in rat urine of Alzheimer's disease using in situ ultrasound-assisted derivatization dispersive liquid-liquid microextraction with UHPLC-MS/MS.
    Zhao XE; He Y; Li M; Chen G; Wei N; Wang X; Sun J; Zhu S; You J
    J Pharm Biomed Anal; 2017 Feb; 135():186-198. PubMed ID: 28039808
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Exploratory Analysis of iPSCS-Derived Neuronal Cells as Predictors of Diagnosis and Treatment of Alzheimer Disease.
    Cavalli E; Battaglia G; Basile MS; Bruno V; Petralia MC; Lombardo SD; Pennisi M; Kalfin R; Tancheva L; Fagone P; Nicoletti F; Mangano K
    Brain Sci; 2020 Mar; 10(3):. PubMed ID: 32183090
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice.
    Nilsson P; Loganathan K; Sekiguchi M; Winblad B; Iwata N; Saido TC; Tjernberg LO
    Proteomics; 2015 Oct; 15(19):3349-55. PubMed ID: 26194619
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease.
    Riemens RJM; Kenis G; van den Beucken T
    Neurobiol Learn Mem; 2020 Nov; 175():107318. PubMed ID: 32977028
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.
    Castaño EM; Roher AE; Esh CL; Kokjohn TA; Beach T
    Neurol Res; 2006 Mar; 28(2):155-63. PubMed ID: 16551433
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human induced pluripotent stem cells as a research tool in Alzheimer's disease.
    Robbins JP; Price J
    Psychol Med; 2017 Nov; 47(15):2587-2592. PubMed ID: 28805182
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease.
    Skillbäck T; Mattsson N; Hansson K; Mirgorodskaya E; Dahlén R; van der Flier W; Scheltens P; Duits F; Hansson O; Teunissen C; Blennow K; Zetterberg H; Gobom J
    Sci Rep; 2017 Oct; 7(1):13333. PubMed ID: 29042634
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modeling psychiatric disorders using patient stem cell-derived neurons: a way forward.
    Vadodaria KC; Amatya DN; Marchetto MC; Gage FH
    Genome Med; 2018 Jan; 10(1):1. PubMed ID: 29301565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.